chronic kidney disease. Chronic kidney disease, stage 3 (moderate)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The dosage of medications taken during the past six months did not change during the study Willing to participate in the study and have written consent GFR between 15 and 60 Adults between 18-65 years
Exclusion criteria
Exclusion criteria: Has malignancy AIDS , acute or inflammatory infection , diabetes patient , cancer patients , decompensated HF patient, renal transplant recipients , dialysis patients , Alzheimer's patients , patients Cognitive problems, patients with mental illness , pregnant patients or those who plan to be pregnant during the study period , the patient's death during the study , the patient's unwillingness to participate and participate in training sessions , the participant with motor impairment (weakness) Musculoskeletal), treatment regimen over the past month , loss of inclusion criteria decline GFR
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EGFR. Timepoint: At the beginning of the study (before the intervention) and six months after the start of treatment and nutrition training. Method of measurement: formula. | — |
Secondary
| Measure | Time frame |
|---|---|
| BUN. Timepoint: At the beginning of the study (before the intervention) and six months after the start of treatment and nutrition training. Method of measurement: Autoanalyser.;Cratinine. Timepoint: At the beginning of the study (before the intervention) and six months after the start of treatment and nutrition training. Method of measurement: Autoanalyser.;Albumin. Timepoint: At the beginning of the study (before the intervention) and six months after the start of treatment and nutrition training. Method of measurement: Autoanalyser.;Calcium. Timepoint: At the beginning of the study (before the intervention) and six months after the start of treatment and nutrition training. Method of measurement: Autoanalyser.;Sodium. Timepoint: At the beginning of the study (before the intervention) and six months after the start of treatment and nutrition training. Method of measurement: Autoanalyser.;Phosphor. Timepoint: At the beginning of the study (before the intervention) and six months after the start of treatment and nutrition training. Method of measurement: Autoanalyser.;Potasium. Timepoint: At the beginning of the study (before the intervention) and six months after the start of treatment and nutrition training. Method of measurement: Autoanalyser.;Hemoglobin. Timepoint: At the beginning of the study (before the intervention) and six months after the start of treatment and nutrition training. Method of measurement: Autoanalyser.;Uric acid. Timepoint: At the beginning of the study (before the intervention) and six months after the start of treatment and nutrition training. Method of measurement: Autoanalyser.;Hematocrit. Timepoint: At the beginning of the study (before the intervention) and six months after the start of treatment and nutrition training. Method of measurement: Autoanalyser.;Weight. Timepoint: At the beginning of the study (before the intervention) and six months after the start of treatment and nutrition training. Method of measurement: scale.;BMI. Timep | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences